BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/6/2024 6:10:51 AM | Browse: 48 | Download: 58
Publication Name World Journal of Gastroenterology
Manuscript ID 89799
Country Pakistan
Received
2023-11-13 08:45
Peer-Review Started
2023-11-13 08:46
To Make the First Decision
Return for Revision
2023-12-07 06:26
Revised
2024-01-03 00:07
Second Decision
2024-01-29 02:04
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2024-01-29 02:21
Articles in Press
2024-01-29 02:21
Publication Fee Transferred
Edit the Manuscript by Language Editor
2024-02-04 00:39
Typeset the Manuscript
2024-02-26 05:46
Publish the Manuscript Online
2024-03-06 06:10
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Guidelines
Article Title National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma
Manuscript Source Unsolicited Manuscript
All Author List Faisal Saud Dar, Zaigham Abbas, Irfan Ahmed, Muhammad Atique, Usman Iqbal Aujla, Muhammad Azeemuddin, Zeba Aziz, Abu Bakar Hafeez Bhatti, Tariq Ali Bangash, Amna Subhan Butt, Osama Tariq Butt, Abdul Wahab Dogar, Javed Iqbal Farooqi, Faisal Hanif, Jahanzaib Haider, Siraj Haider, Syed Mujahid Hassan, Adnan Abdul Jabbar, Aman Nawaz Khan, Muhammad Shoaib Khan, Muhammad Yasir Khan, Amer Latif, Nasir Hassan Luck, Ahmed Karim Malik, Kamran Rashid, Sohail Rashid, Mohammad Salih, Abdullah Saeed, Amjad Salamat, Ghias-un-Nabi Tayyab, Aasim Yusuf, Haseeb Haider Zia and Ammara Naveed
ORCID
Author(s) ORCID Number
Zaigham Abbas http://orcid.org/0000-0002-9513-5324
Abu Bakar Hafeez Bhatti http://orcid.org/0000-0002-4875-603X
Amna Subhan Butt http://orcid.org/0000-0002-7311-4055
Javed Iqbal Farooqi http://orcid.org/0000-0002-5467-644X
Nasir Hassan Luck http://orcid.org/0000-0002-4752-4157
Ammara Naveed http://orcid.org/0000-0003-4968-3810
Funding Agency and Grant Number
Corresponding Author Ammara Naveed, MBBS, Assistant Professor, Department of Gastroenterology & Hepatology, Pakistan Kidney and Liver Institute & Research Centre, DHA Phase VI Lahore, Lahore 54000, Pakistan. ammara.naveed@pkli.org.pk
Key Words Hilar cholangiocarcinoma; Bismuth-Corlette classification; Memorial Sloan Kettering Cancer Centre Staging; Preoperative biliary drainage; Portal vein embolisation; Surgical resection; Hepatectomy
Core Tip Consensus among national hepatobiliary experts convened at the Pakistan Kidney and Liver Institute & Research Centre emphasized the complexity of hilar cholangiocarcinoma (hCCA), advocating a multidisciplinary approach for optimal patient management. Diagnostic protocol includes imaging like computed tomography, magnetic resonance imaging, and magnetic resonance cholangiopancreatography, while endoscopic retrograde cholangiopancreatography plays an important role in tissue acquisition. Surgical resection remains the best curative treatment option. For unresectable cases, liver transplantation is considered under strict selection criteria. Preoperative biliary drainage and portal vein embolisation decisions may be needed for selective cases. Adjuvant chemotherapy addresses the risk of recurrence. The role of Immunotherapy is emerging and offers improved survival for irresectable hCCA.
Publish Date 2024-03-06 06:10
Citation Dar FS, Abbas Z, Ahmed I, Atique M, Aujla UI, Azeemuddin M, Aziz Z, Bhatti ABH, Bangash TA, Butt AS, Butt OT, Dogar AW, Farooqi JI, Hanif F, Haider J, Haider S, Hassan SM, Jabbar AA, Khan AN, Khan MS, Khan MY, Latif A, Luck NH, Malik AK, Rashid K, Rashid S, Salih M, Saeed A, Salamat A, Tayyab GUN, Yusuf A, Zia HH, Naveed A. National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma. World J Gastroenterol 2024; 30(9): 1018-1042
URL https://www.wjgnet.com/1007-9327/full/v30/i9/1018.htm
DOI https://dx.doi.org/10.3748/wjg.v30.i9.1018
Full Article (PDF) WJG-30-1018-with-cover.pdf
Manuscript File 89799-Review-FilipodiaCL.docx
Answering Reviewers 89799-Answering reviewers.pdf
Audio Core Tip 89799-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 89799-Conflict-of-interest statement.pdf
Copyright License Agreement 89799-Copyright license agreement.pdf
Peer-review Report 89799-Peer-review(s).pdf
Scientific Misconduct Check 89799-Bing-Chen YL-2.png
Scientific Editor Work List 89799-Scientific editor work list.pdf